Literature DB >> 481659

Perinephric abscess in patients with polycystic kidney disease undergoing chronic hemodialysis.

R Sweet, W F Keane.   

Abstract

5 patients with polycystic kidney disease undergoing chronic hemodialysis who developed perinephric abscesses are described. Gallium-67 scintigraphy was helpful in making a diagnosis in 2 of these patients. All 5 patients initially presented with urinary tract infections. Perinephric abscess became evident over a variable period of time (2--28 days) following completion of antibiotic therapy for their urinary tract infection. Gallium-67 scintigraphy appears useful in detecting this complication, and nephrectomy should be considered once the diagnosis is confirmed.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 481659     DOI: 10.1159/000181642

Source DB:  PubMed          Journal:  Nephron        ISSN: 1660-8151            Impact factor:   2.847


  5 in total

1.  Infected liver cyst in a patient with polycystic kidney disease.

Authors:  N Gesundheit; D L Kent; H D Fawcett; M K Effron; R H Maffly
Journal:  West J Med       Date:  1982-03

Review 2.  Perinephric and intranephric abscesses: a review of the literature.

Authors:  J Saiki; N D Vaziri; C Barton
Journal:  West J Med       Date:  1982-02

3.  Ciprofloxacin activity in cyst fluid from polycystic kidneys.

Authors:  L W Elzinga; T A Golper; A L Rashad; M E Carr; W M Bennett
Journal:  Antimicrob Agents Chemother       Date:  1988-06       Impact factor: 5.191

4.  Salmonella Renal Abscess in an Immunocompetent Child: Case Report and Literature Review.

Authors:  Cedric Wei Ming Poh; Xue Fen Valerie Seah; Chia Yin Chong; Indra Ganesan; Matthias Maiwald; Karen Nadua; Kai-Qian Kam; Natalie Woon Hui Tan
Journal:  Glob Pediatr Health       Date:  2021-05-31

5.  Developments in the management of autosomal dominant polycystic kidney disease.

Authors:  Amirali Masoumi; Berenice Reed-Gitomer; Catherine Kelleher; Mir Reza Bekheirnia; Robert W Schrier
Journal:  Ther Clin Risk Manag       Date:  2008-04       Impact factor: 2.423

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.